BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28966010)

  • 21. Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience.
    Madigan CE; Armenian SH; Malogolowkin MH; Mascarenhas L
    Cancer; 2007 Nov; 110(9):2061-6. PubMed ID: 17828773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
    Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INI1/SMARCB1-Deficient Carcinoma (Rhabdoid Tumor) of the Lacrimal Gland.
    Srinivasan A; Tuluc M; Jordan AJ; Curry JM; Bilyk JR
    Ophthalmic Plast Reconstr Surg; 2019; 35(2):e41-e43. PubMed ID: 30856630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep intronic hotspot variant explaining rhabdoid tumor predisposition syndrome in two patients with atypical teratoid and rhabdoid tumor.
    Tauziède-Espariat A; Masliah-Planchon J; Brugières L; Puget S; Dufour C; Schneider P; Laquerrière A; Frebourg T; Bodet D; Lechapt-Zalcman E; Pierron G; Delattre O; Varlet P; Bourdeaut F
    Eur J Hum Genet; 2017 Oct; 25(10):1170-1172. PubMed ID: 28722703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Strategy Involving High-Dose Chemotherapy with Stem Cell Rescue Followed by Intrathecal Topotecan Maintenance Therapy without Whole-Brain Irradiation for Atypical Teratoid/Rhabdoid Tumors.
    Yamada A; Kinoshita M; Kamimura S; Jinnouchi T; Azuma M; Yamashita S; Yokogami K; Takeshima H; Moritake H
    Pediatr Hematol Oncol; 2023; 40(7):629-642. PubMed ID: 37519026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
    Bourdeaut F; Chi SN; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous Central Nervous System Atypical Teratoid/Rhabdoid Tumor and Malignant Rhabdoid Tumor of the Kidney: Case Report of a Long-Term Survivor and Review of the Literature.
    Abu Arja MH; Patel P; Shah SH; Auletta JJ; Meyer EK; Conley SE; Aldrink JH; Pindrik JA; AbdelBaki MS
    World Neurosurg; 2018 Mar; 111():6-15. PubMed ID: 29223518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor.
    Fukushima H; Yamasaki K; Sakaida M; Tsujio N; Okuno T; Ishii N; Okada K; Fujisaki H; Matsusaka Y; Sakamoto H; Yoneda A; Hara J; Inoue T
    Pathol Int; 2021 Feb; 71(2):155-160. PubMed ID: 33378586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).
    Kordes U; Bartelheim K; Modena P; Massimino M; Biassoni V; Reinhard H; Hasselblatt M; Schneppenheim R; Frühwald MC
    Pediatr Blood Cancer; 2014 May; 61(5):919-21. PubMed ID: 24123847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007.
    Bartelheim K; Nemes K; Seeringer A; Kerl K; Buechner J; Boos J; Graf N; Dürken M; Gerss J; Hasselblatt M; Kortmann RD; Teichert von Luettichau I; Nagel I; Nygaard R; Oyen F; Quiroga E; Schlegel PG; Schmid I; Schneppenheim R; Siebert R; Solano-Paez P; Timmermann B; Warmuth-Metz M; Frühwald MC
    Cancer Med; 2016 Aug; 5(8):1765-75. PubMed ID: 27228363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMARCB1/INI1-deficient tumors of adulthood.
    Parker NA; Al-Obaidi A; Deutsch JM
    F1000Res; 2020; 9():662. PubMed ID: 33796273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
    Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
    Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicentric atypical teratoid/rhabdoid tumors occurring in the eye and fourth ventricle of an infant: case report.
    Fujita M; Sato M; Nakamura M; Kudo K; Nagasaka T; Mizuno M; Amano E; Okamoto Y; Hotta Y; Hatano H; Nakahara N; Wakabayashi T; Yoshida J
    J Neurosurg; 2005 Apr; 102(3 Suppl):299-302. PubMed ID: 15881754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverse outcomes in extra-cranial rhabdoid tumors: A single institute experience.
    Katsumi Y; Iehara T; Kuwahara Y; Tsuchiya K; Konishi E; Hosoi H
    Pediatr Hematol Oncol; 2022 Apr; 39(3):278-285. PubMed ID: 34668815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology and diagnosis of SMARCB1-deficient tumors.
    Margol AS; Judkins AR
    Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
    Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
    Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333.
    Reddy AT; Strother DR; Judkins AR; Burger PC; Pollack IF; Krailo MD; Buxton AB; Williams-Hughes C; Fouladi M; Mahajan A; Merchant TE; Ho B; Mazewski CM; Lewis VA; Gajjar A; Vezina LG; Booth TN; Parsons KW; Poss VL; Zhou T; Biegel JA; Huang A
    J Clin Oncol; 2020 Apr; 38(11):1175-1185. PubMed ID: 32105509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
    Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
    Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.